A Prospective, Multicentric, Observational Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life RA Patients Treated With Abatacept SC

Trial Profile

A Prospective, Multicentric, Observational Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life RA Patients Treated With Abatacept SC

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2018

At a glance

  • Drugs Abatacept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms TIGHT
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 11 Jul 2018 Planned End Date changed from 30 Jun 2021 to 4 Aug 2021.
    • 11 Jul 2018 Planned primary completion date changed from 30 Jun 2021 to 4 Aug 2019.
    • 11 Jul 2018 Status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top